Aβ pathology has been established to precede other downstream pathological features, suggesting that amyloid peptide secretion and aggregation are key pathogenic events in AD pathogenesis. However, the exact chain of events underlying amyloid pathology and AD pathogenesis are still not fully understood hampering the development of any curative treatments with significant clinical and socioeconomic consequences .